Longeveron LLC (LGVN : NASDAQ)
Common Stock
Follow LGVN
LGVN
Longeveron LLC
WealthAwesomePerformance
1 Day
+41.29%
1 Week
+59.55%
1 Month
+14.52%
YTD
-66.19%
The Tuesday Stock Pick · free, every tuesday morning. One Canadian stock and the case for it.
Key Statistics
Market Cap
$9.05M
52W High
$12.30
52W Low
$1.31
P/E Ratio
-
50 Day MA
$3.23
200 Day MA
$6.52
Beta
0.91
Dividend Yield
-
Performance history
LGVN returns since 2026
Longeveron LLC has traded since Jun 2026 in our data. Its deepest fall was −83.5% (Aug 2026 to Oct 2026).
1 year / yr
—
3 years / yr
—
5 years / yr
—
10 years / yr
—
Calendar-year returns
- 2026*−66.2%
* Partial year (first year of data, or year to date).
$10,000 invested in LGVN
- 2026 (start of our data)$3,381
- All-time high in our data
- $8 on Aug 21, 2026 · now −66.4%
Total-return basis using adjusted daily closes from the Toronto Stock Exchange and TSX Venture (dividends and splits folded in), Jun 2026 to Nov 2026. Past returns do not predict future ones.
Awesome Portfolio™
Looking past LGVN? Our 10 best Canadian stocks, in one list.
14.8% a year since 2017 against 9.7% for the S&P/TSX Composite (+5.0 points a year). Reviewed every month.
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 11/10/2026 | $2.08 | $2.86 | $1.98 | $2.84 | $2.84 | 668,751 |
| 11/9/2026 | $1.84 | $2.12 | $1.83 | $2.01 | $2.01 | 73,055 |
| 11/6/2026 | $1.75 | $1.83 | $1.70 | $1.81 | $1.81 | 38,800 |
| 11/5/2026 | $1.80 | $1.80 | $1.66 | $1.71 | $1.71 | 34,442 |
| 11/4/2026 | $1.76 | $1.82 | $1.75 | $1.78 | $1.78 | 61,400 |
| 11/3/2026 | $1.71 | $1.80 | $1.71 | $1.78 | $1.78 | 38,108 |
| 11/2/2026 | $1.74 | $1.79 | $1.66 | $1.71 | $1.71 | 58,475 |
| 10/30/2026 | $1.78 | $1.80 | $1.58 | $1.67 | $1.67 | 80,700 |
| 10/29/2026 | $1.75 | $1.83 | $1.73 | $1.75 | $1.75 | 62,767 |
| 10/28/2026 | $1.74 | $1.83 | $1.70 | $1.78 | $1.78 | 77,660 |
Analyst Price Targets
Based on 1 analyst covering LGVN · as of Nov 9, 2026
Wall Street analysts forecast LGVN stock price to rise 2056.7% over the next 12 months.
Consensus
Strong Buy5.00 / 5.00
Avg. Target
US$61.25
+2056.7% Upside
Current Price
US$2.84
Last close
Analyst Breakdown (1 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on LGVN's historical volatility
30-Day Vol
152.4%
Annualized
90-Day Vol
189.0%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
US$2.38
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | US$2.68 | US$1.58 – US$4.53 |
| 60 trading days | US$2.52 | US$1.20 – US$5.30 |
| 90 trading days | US$2.38 | US$0.96 – US$5.91 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Longeveron LLC
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 3 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer's disease, as well as in phase 2b clinical trial to treat aging frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.
Financials
- Revenue (TTM)
- $1.19M
- EBITDA
- $-22.44M
- Profit Margin
- 0.00%
- ROE (TTM)
- -203.61%
- EPS (Diluted)
- -9.90
- Book Value
- 3.28
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Free newsletter
The Tuesday Stock Pick
One Canadian stock and the case for it
- The name with the biggest gap to analyst targets
- The chart, insider buying and what is driving it
- A plain-English bottom line, no hype
Explore More
Common Questions About LGVN.US
Market movers
Recent NASDAQ movers
Top 1-day gainers — updated from our Canadian movers feed.
| Ticker | Name | Price | 1D |
|---|---|---|---|
| SMX | SMX (Security Matters) Public Limited Company Class A Ordinary Shares | $19.25 | +105.88% |
| PEPG | PepGen Ltd | $4.61 | +92.89% |
| TTEC | TTEC Holdings Inc | $2.40 | +72.04% |
| NNOX | Nano X Imaging Ltd | $0.37 | +59.80% |
| TANH | Tantech Holdings Ltd | $30.56 | +58.01% |
| AACG | ATA Creativity Global | $0.89 | +52.14% |
| ESLA | Estrella Immunopharma Inc. | $0.75 | +45.40% |
| MNDO | MIND CTI Ltd | $1.26 | +44.83% |